Search results
Showing 6361 to 6375 of 9059 results
Recommendation ID IPG619/1 Question Research on the safety and efficacy of superior capsular augmentation for massive rotator cuff tears
Recommendation ID NG50/8 Question Acute hepatic encephalopathy:- In people with cirrhosis and an acute episode of hepatic encephalopathy
Recommendation ID NG52/2 Question Factors predicting outcomes for people with high-grade transformation of follicular lymphoma:- In people
Recommendation ID NG52/1 Question Baseline FDG-PET-CT imaging for people with diffuse large B-cell lymphoma stage II or above:- In people
Recommendation ID NG52/3 Question Radiotherapy in first-line treatment of diffuse large B-cell lymphoma:- In people presenting with diffuse
Saving babies' hearing: how a world-first rapid genetic test is transforming neonatal care
Learn how NICE's healthtech guidance helped bring life-changing genetic testing to neonatal units across the UK, saving 20 babies' hearing so far with potential to prevent hearing loss in 200 babies annually.
New functionality for online collaboration on consultations, enables groups or organisations to submit a joined-up response.
Neonatal infection guidance updated to allow home antibiotic treatment for some babies
We’ve recommended that newborn babies receiving antibiotics in hospital could potentially switch to oral antibiotics and be cared for at home if they are doing well and responding to treatment.
Home News Podcasts Treating babies at home with oral antibiotics Podcasts 27 May 2026 Listen About this episode In this episode we discuss
First new NHS treatment in over 20 years recommended for women with resistant ovarian cancer
The treatment uses a targeted therapy that seeks out a specific protein found on the surface of cancer cells and delivers a cancer-killing medicine directly to them.
NICE issues new guidance on 'artificial pancreas' technology for pregnant women with type 1 diabetes
Women with type 1 diabetes who are pregnant or planning a pregnancy should be offered a pregnancy-specific 'artificial pancreas' device. That is the recommendation in draft guidance published today by NICE.
Why flexibility is built into everything we do at NICE Advice
No two products are the same, so no two NICE Advice projects should be either. Andrew Walsh explains how NICE Advice adapts its services to fit your situation.
Our associate director of NICE Advice outlines his top tips for healthtech companies, helping them chart a clear path from innovation to NHS adoption.
Learn how NICE's healthtech guidance is accelerating NHS adoption of a simple bowel cancer test, preventing 140,000 unnecessary urgent referrals a year while keeping cancer detection rates stable.
From £1 to £180: how NICE guidance helped us make smarter slide sheet choices
Learn how our evidence-based guidance helped a London NHS trust standardise procurement and generate operational efficiencies.